139 related articles for article (PubMed ID: 26341758)
21. Factors associated with decreased ovarian reserve in Crohn's disease: A systematic review and meta-analysis.
Foulon A; Richard N; Guichard C; Yzet C; Breuval C; Gondry J; Cabry-Goubet R; Michaud A; Fumery M
Acta Obstet Gynecol Scand; 2024 May; ():. PubMed ID: 38803058
[TBL] [Abstract][Full Text] [Related]
22. Understanding the barriers to, and facilitators of, ovarian toxicity assessment in breast cancer clinical trials.
Cui W; Phillips KA; Francis PA; Anderson RA; Partridge AH; Loi S; Loibl S; Keogh L
Breast; 2022 Aug; 64():56-62. PubMed ID: 35597179
[TBL] [Abstract][Full Text] [Related]
23. Comparing the Gonadotoxicity of Multiple Breast Cancer Regimens: Important Understanding for Managing Breast Cancer in Pre-Menopausal Women.
Martelli V; Latocca MM; Ruelle T; Perachino M; Arecco L; Beshiri K; Razeti MG; Tagliamento M; Cosso M; Fregatti P; Lambertini M
Breast Cancer (Dove Med Press); 2021; 13():341-351. PubMed ID: 34079366
[TBL] [Abstract][Full Text] [Related]
24. Breast cancer: an update on treatment-related infertility.
Silvestris E; Dellino M; Cafforio P; Paradiso AV; Cormio G; D'Oronzo S
J Cancer Res Clin Oncol; 2020 Mar; 146(3):647-657. PubMed ID: 32006118
[TBL] [Abstract][Full Text] [Related]
25. Reproductive potential and performance of fertility preservation strategies in BRCA-mutated breast cancer patients.
Lambertini M; Goldrat O; Ferreira AR; Dechene J; Azim HA; Desir J; Delbaere A; t'Kint de Roodenbeke MD; de Azambuja E; Ignatiadis M; Demeestere I
Ann Oncol; 2018 Jan; 29(1):237-243. PubMed ID: 29045555
[TBL] [Abstract][Full Text] [Related]
26. Anti-Müllerian hormone in breast cancer patients treated with chemotherapy: a retrospective evaluation of subsequent pregnancies.
Hamy AS; Porcher R; Eskenazi S; Cuvier C; Giacchetti S; Coussy F; Hocini H; Tournant B; Perret F; Bonfils S; Charvériat P; Lacorte JM; Espie M
Reprod Biomed Online; 2016 Mar; 32(3):299-307. PubMed ID: 26803206
[TBL] [Abstract][Full Text] [Related]
27. Ovarian suppression using luteinizing hormone-releasing hormone agonists during chemotherapy to preserve ovarian function and fertility of breast cancer patients: a meta-analysis of randomized studies.
Lambertini M; Ceppi M; Poggio F; Peccatori FA; Azim HA; Ugolini D; Pronzato P; Loibl S; Moore HC; Partridge AH; Bruzzi P; Del Mastro L
Ann Oncol; 2015 Dec; 26(12):2408-19. PubMed ID: 26347105
[TBL] [Abstract][Full Text] [Related]
28. The utility of anti-Müllerian hormone in the diagnosis and prediction of loss of ovarian function following chemotherapy for early breast cancer.
Anderson RA; Mansi J; Coleman RE; Adamson DJA; Leonard RCF
Eur J Cancer; 2017 Dec; 87():58-64. PubMed ID: 29117576
[TBL] [Abstract][Full Text] [Related]
29. A New Model Including AMH Cut-off Levels to Predict Post-treatment Ovarian Function in Early Breast Cancer: A Prospective Cohort Study.
Omranipour R; Ahmadi-Harchegani F; Saberi A; Moini A; Shiri M; Jalaeefar A; Arian A; Seifollahi A; Madani M; Eslami B; Alipour S
Arch Iran Med; 2024 Feb; 27(2):96-104. PubMed ID: 38619033
[TBL] [Abstract][Full Text] [Related]
30. Anti-Müllerian hormone beyond an ovarian reserve marker: the relationship with the physiology and pathology in the life-long follicle development.
Iwase A; Hasegawa Y; Tsukui Y; Kobayashi M; Hiraishi H; Nakazato T; Kitahara Y
Front Endocrinol (Lausanne); 2023; 14():1273966. PubMed ID: 38027144
[TBL] [Abstract][Full Text] [Related]
31. Diagnostic and predictive accuracy of anti-mullerian hormone for ovarian function after chemotherapy in premenopausal women with early breast cancer.
Anderson RA; Kelsey TW; Perdrix A; Olympios N; Duhamel O; Lambertini M; Clatot F
Breast Cancer Res Treat; 2022 Apr; 192(2):273-282. PubMed ID: 34997365
[TBL] [Abstract][Full Text] [Related]
32. ESHRE guideline: female fertility preservation.
; Anderson RA; Amant F; Braat D; D'Angelo A; Chuva de Sousa Lopes SM; Demeestere I; Dwek S; Frith L; Lambertini M; Maslin C; Moura-Ramos M; Nogueira D; Rodriguez-Wallberg K; Vermeulen N
Hum Reprod Open; 2020; 2020(4):hoaa052. PubMed ID: 33225079
[TBL] [Abstract][Full Text] [Related]
33. Fertility preservation in breast cancer with case-based examples for guidance.
Hampe ME; Rhoton-Vlasak AS
J Assist Reprod Genet; 2020 Mar; 37(3):717-729. PubMed ID: 32008180
[TBL] [Abstract][Full Text] [Related]
34. Post-chemotherapy serum anti-Müllerian hormone level predicts ovarian function recovery.
Kim HA; Choi J; Park CS; Seong MK; Hong SE; Kim JS; Park IC; Lee JK; Noh WC;
Endocr Connect; 2018 Aug; 7(8):949-956. PubMed ID: 30300533
[TBL] [Abstract][Full Text] [Related]
35. Determinants of ovarian function after response-adapted therapy in patients with advanced Hodgkin's lymphoma (RATHL): a secondary analysis of a randomised phase 3 trial.
Anderson RA; Remedios R; Kirkwood AA; Patrick P; Stevens L; Clifton-Hadley L; Roberts T; Hatton C; Kalakonda N; Milligan DW; McKay P; Rowntree C; Scott FM; Johnson PWM
Lancet Oncol; 2018 Oct; 19(10):1328-1337. PubMed ID: 30220622
[TBL] [Abstract][Full Text] [Related]
36. Antral Follicles Count and Anti-Müllerian Hormone Levels after Gonadotoxic Chemotherapy in Patients with Breast Cancer: Cohort Study.
D'Avila ÂM; Capp E; Corleta HVE
Rev Bras Ginecol Obstet; 2017 Apr; 39(4):162-168. PubMed ID: 28399596
[No Abstract] [Full Text] [Related]
37. Predicting Ovarian Activity in Women Affected by Early Breast Cancer: A Meta-Analysis-Based Nomogram.
Barnabei A; Strigari L; Marchetti P; Sini V; De Vecchis L; Corsello SM; Torino F
Oncologist; 2015 Oct; 20(10):1111-8. PubMed ID: 26341758
[TBL] [Abstract][Full Text] [Related]
38. Anti-müllerian hormone levels and evolution in women of reproductive age with breast cancer treated with chemotherapy.
Fréour T; Barrière P; Masson D
Eur J Cancer; 2017 Mar; 74():1-8. PubMed ID: 28135602
[TBL] [Abstract][Full Text] [Related]
39. Pretreatment anti-Müllerian hormone predicts for loss of ovarian function after chemotherapy for early breast cancer.
Anderson RA; Rosendahl M; Kelsey TW; Cameron DA
Eur J Cancer; 2013 Nov; 49(16):3404-11. PubMed ID: 23968732
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
